• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

African drugmaker Aspen bets on GLP-1 drugs to boost profit

cafead

Administrator
Staff member
  • cafead   Sep 03, 2024 at 06:12: PM
via
  • Aspen's FY core profit up 1%
  • Secures licence to commercialise GLP-1 drugs
  • Eli Lilly's Mounjaro could launch by year-end in S.Africa

article source